Aquilion ONE (TSX-306A/3) V10.0 with Spectral Imaging System

The Aquilion ONE (TSX-306A/3) V10.0 with Spectral Imaging System is an advanced computed tomography scanner designed for comprehensive whole-body and single-rotation whole-organ imaging, with a focus on enhancing diagnostic information while managing radiation dose. Its methodology combines rapid KV switching for spectral imaging to differentiate material compositions, FIRST iterative reconstruction for dose reduction and improved spatial resolution, and an AiCE Deep Convolutional Neural Network for substantial noise reduction and image quality enhancement, supported by performance testing demonstrating these capabilities.

The Aquilion ONE (TSX-306A/3) V10.0 with Spectral Imaging System is a whole-body multi-slice helical CT scanner, comprising a gantry, couch, and console for data processing and display. Its primary purpose is to acquire and display cross-sectional volumes of the entire body, including the head, with the capability to image whole organs such as the brain, heart, and pancreas in a single rotation. These comprehensive volume datasets enable trained physicians to perform specialized studies of entire organs, facilitating detailed anatomical assessment for determining courses of treatment. The system integrates several advanced imaging technologies to enhance diagnostic capabilities. The Spectral Imaging System utilizes rapid KV switching to acquire two nearly simultaneous CT images at distinct energy levels, allowing for differentiation of material composition in organs, tissues, and contrast agents; the total X-ray dose is the sum of the doses from each energy level. It incorporates FIRST, an iterative reconstruction algorithm designed to reduce radiation exposure dose while improving high-contrast spatial resolution for applications including the abdomen, pelvis, chest, cardiac, extremities, and head. Additionally, AiCE, a noise reduction algorithm employing Deep Convolutional Neural Network methods, enhances image quality and reduces noise in scans of the abdomen, pelvis, lung, cardiac, brain, inner ear, and extremities. Performance testing confirmed the diagnostic quality of images, with AiCE demonstrating significant dose reduction (e.g., 69-81% compared to filtered back projection), improved low-contrast detectability, and noise reduction, while Spectral Imaging showed reduced beam hardening artifacts and a high linear correlation between CT number and iodine concentration.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What is the quantitative impact of the FIRST algorithm on exposure dose and high-contrast spatial resolution across different anatomical regions, and how does this compare to other iterative reconstruction techniques?; How does the AiCE algorithm's Deep Convolutional Neural Network specifically differentiate between noise and fine anatomical detail, particularly in low-dose pediatric scans or in regions with inherently low contrast?; What are the specific advantages and limitations of rapid KV switching in the Spectral Imaging System for quantitative material decomposition (e.g., accuracy of iodine maps, virtual non-contrast images) compared to dual-source or detector-based spectral CT approaches?; The document mentions a "high linear correlation between CT number and iodine concentration." What is the validated range and precision of this correlation, and how does it perform across different patient body habitus or contrast administration protocols?; Given the distinct benefits of AiCE (noise/dose reduction) and Spectral Imaging (material differentiation), what are the optimal acquisition and reconstruction protocols when both features are employed simultaneously, and are there any synergistic effects or trade-offs observed in image quality or diagnostic information?